Have a personal or library account? Click to login
Hydrazinyldiene-chroman-2,4-diones in inducing growth arrest and apoptosis in breast cancer cells: Synergism with doxorubicin and correlation with physicochemical properties Cover

Hydrazinyldiene-chroman-2,4-diones in inducing growth arrest and apoptosis in breast cancer cells: Synergism with doxorubicin and correlation with physicochemical properties

Acta Pharmaceutica
Volume 67 (2017): Issue 1 (March 2017)
By: Lulzime Ballazhi,  Faik Imeri,  Ahmed Jashari,  Emil Popovski,  Goran Stojković,  Aleksandar J. Dimovski,  Bozhana Mikhova and  Kristina Mladenovska  
Open Access
|Feb 2017
DOI: https://doi.org/10.1515/acph-2017-0006 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Journal RSS Feed
Language: English
Page range: 35 - 52
Accepted on: Sep 21, 2016
|
Published on: Feb 21, 2017
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
hydrazinyldiene chroman 2,4 diones,
physicochemical properties,
doxorubicin,
cytotoxicity,
breast cancer cells
Related subjects:
Pharmacy,
Pharmacy, other

© 2017 Lulzime Ballazhi, Faik Imeri, Ahmed Jashari, Emil Popovski, Goran Stojković, Aleksandar J. Dimovski, Bozhana Mikhova, Kristina Mladenovska, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous articleVolume 67 (2017): Issue 1 (March 2017)Next article